BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33634678)

  • 1. miR-26b regulates cell proliferation and apoptosis of CD117+CD44+ ovarian cancer stem cells by targeting PTEN.
    Gao Z; Ye X; Bordeaux A; Hettich S; Lin S; Han F; Jia Y
    Eur J Histochem; 2021 Feb; 65(1):. PubMed ID: 33634678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-301a Promotes Cell Proliferation and Resistance to Apoptosis through PTEN/PI3K/Akt Signaling Pathway in Human Ovarian Cancer.
    Ni J; Chen Y; Fei B; Zhu Y; Du Y; Liu L; Guo L; Zhu W
    Gynecol Obstet Invest; 2021; 86(1-2):108-116. PubMed ID: 33596588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.
    Yin G; Chen R; Alvero AB; Fu HH; Holmberg J; Glackin C; Rutherford T; Mor G
    Oncogene; 2010 Jun; 29(24):3545-53. PubMed ID: 20400975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN.
    Zhao D; Chen Y; Chen S; Zheng C; Hu J; Luo S
    Tumour Biol; 2017 May; 39(5):1010428317705341. PubMed ID: 28475001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.
    Chen J; Wang J; Chen D; Yang J; Yang C; Zhang Y; Zhang H; Dou J
    BMC Cell Biol; 2013 Jan; 14():7. PubMed ID: 23368632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of microRNA expression profiles of CD44
    Wang L; Zhi X; Lu Y; Cong Y; Fu Z; Cao J; Xu S; Lv J; Ruan H
    Arch Gynecol Obstet; 2022 Aug; 306(2):461-472. PubMed ID: 35076757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway.
    Ni J; Chen L; Ling L; Wu M; Ren Q; Zhu W
    Mol Med Rep; 2020 Aug; 22(2):1277-1284. PubMed ID: 32626994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
    Cheng W; Liu T; Wan X; Gao Y; Wang H
    FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
    Li J; Jiang K; Zhao F
    Oncol Rep; 2015 Jun; 33(6):2829-36. PubMed ID: 25845681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
    Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
    Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA-9119 suppresses in ovarian cancer cell viability via targeting the microRNA-21-5p-PTEN-Akt pathway.
    Gong J; Xu X; Zhang X; Zhou Y
    Aging (Albany NY); 2020 Jul; 12(14):14314-14328. PubMed ID: 32675386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
    Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
    Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation.
    Boscaro C; Baggio C; Carotti M; Sandonà D; Trevisi L; Cignarella A; Bolego C
    FASEB J; 2022 Mar; 36(3):e22140. PubMed ID: 35107852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN.
    Liang N; Zhou X; Zhao M; Zhao D; Zhu Z; Li S; Yang H
    Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):530-8. PubMed ID: 26068649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA 26b promotes colorectal cancer metastasis by downregulating phosphatase and tensin homolog and wingless-type MMTV integration site family member 5A.
    Fan D; Lin X; Zhang F; Zhong W; Hu J; Chen Y; Cai Z; Zou Y; He X; Chen X; Lan P; Wu X
    Cancer Sci; 2018 Feb; 109(2):354-362. PubMed ID: 29160937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.